185 related articles for article (PubMed ID: 25652785)
21. Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment.
Albanna W; Weiss M; Conzen C; Clusmann H; Schneider T; Reinsch M; Müller M; Wiesmann M; Höllig A; Schubert GA
World Neurosurg; 2017 Jun; 102():459-465. PubMed ID: 28344178
[TBL] [Abstract][Full Text] [Related]
22. Perioperative changes in cerebral ischemic markers in the cerebrospinal fluid after preoperative nimodipine treatment.
Oehmke MJ; Schirrmeister D; Kuhn DF; Fritz T; Engel J; Hempelmann G
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1287-91. PubMed ID: 14616329
[TBL] [Abstract][Full Text] [Related]
23. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage.
Vinge E; Andersson KE; Brandt L; Ljunggren B; Nilsson LG; Rosendal-Helgesen S
Eur J Clin Pharmacol; 1986; 30(4):421-5. PubMed ID: 3743617
[TBL] [Abstract][Full Text] [Related]
25. Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
Onal MB; Civelek E; Kircelli A; Solmaz I; Ugurel S; Narin F; Isikay I; Bilginer B; Yakupoglu H
Acta Neurochir Suppl; 2011; 110(Pt 2):23-8. PubMed ID: 21125440
[TBL] [Abstract][Full Text] [Related]
26. Nimodipine transfer into human breast milk and cerebrospinal fluid.
Carcas AJ; Abad-Santos F; de Rosendo JM; Frias J
Ann Pharmacother; 1996 Feb; 30(2):148-50. PubMed ID: 8835048
[TBL] [Abstract][Full Text] [Related]
27. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
28. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
[TBL] [Abstract][Full Text] [Related]
29. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
[TBL] [Abstract][Full Text] [Related]
31. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).
Voldby B; Petersen OF; Buhl M; Jakobsen P; Ostergaard R
Acta Neurochir (Wien); 1984; 70(3-4):243-54. PubMed ID: 6546832
[TBL] [Abstract][Full Text] [Related]
32. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
[TBL] [Abstract][Full Text] [Related]
33. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous administration of nimodipine improves bioavailability in rabbits.
Laslo AM; Eastwood JD; Urquhart B; Lee TY; Freeman D
J Neurosci Methods; 2004 Oct; 139(2):195-201. PubMed ID: 15488232
[TBL] [Abstract][Full Text] [Related]
35. Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption.
Fu Q; Sun J; Ai X; Zhang P; Li M; Wang Y; Liu X; Sun Y; Sui X; Sun L; Han X; Zhu M; Zhang Y; Wang S; He Z
Int J Pharm; 2013 May; 448(1):290-7. PubMed ID: 23384726
[TBL] [Abstract][Full Text] [Related]
36. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
[TBL] [Abstract][Full Text] [Related]
37. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
Porchet F; Chioléro R; de Tribolet N
Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
[TBL] [Abstract][Full Text] [Related]
38. Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage - a pilot study.
Soppi V; Kokki H; Koivisto T; Lehtonen M; Helin-Tanninen M; Lehtola S; Rinne J
Eur J Clin Pharmacol; 2007 Apr; 63(4):355-61. PubMed ID: 17318527
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of bioavailability between nimotop and nimodipine tablet].
Shi XJ; Wang HT; Wei Y; Zhang JH; Zhang LL; Zhong MK
Yao Xue Xue Bao; 1997 Sep; 32(9):708-10. PubMed ID: 11596299
[TBL] [Abstract][Full Text] [Related]
40. Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: the critical size in improving bioavailability.
Fu Q; Kou L; Gong C; Li M; Sun J; Zhang D; Liu M; Sui X; Liu K; Wang S; He Z
Int J Pharm; 2012 May; 427(2):358-64. PubMed ID: 22370475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
